EUVIMEDEUVIMED entdecken
Fallbericht

Newly Developing IgM Anti‐ GD1a / GD1b Ganglioside IgM Monoclonal Gammopathy in a Patient With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Ruby F Ross iD, Jennifer A Langsdorf iD, Norman Latov

Journal of the Peripheral Nervous System · 2026-12 · 31 (4)

DOI: 10.1111/jns.70174 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 24.09.2026. Verfasst von Ruby F Ross und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weill Cornell Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Immunoglobulin M, Paraproteinemias, Gangliosides. Die Arbeit nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Chronic inflammatory demyelinating neuropathy (CIDP) is a rare, immune‐mediated neuropathy that is distinct from other immune‐mediated, paraneoplastic, and paraproteinemic neuropathies that may have overlapping clinical features. Identification of the specific diagnosis in each patient is important as each of these disorders has distinct pathophysiology and treatment response. Case Report Here, we present an atypical case of CIDP in which the patient developed an IgM monoclonal gammopathy with positive anti‐ganglioside antibodies over 20 years into his disease course. Interpretation Patients with CIDP may be predisposed to develop IgM autoantibodies or monoclonal gammopathies. If a patient with CIDP experiences clinical worsening while on maintenance therapy, it may be helpful to test for anti‐ganglioside antibodies and monoclonal gammopathies and reassess if alternative treatment would be useful.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingImmunoglobulin MParaproteinemiasGangliosidesAutoantibodiesHumansMale

Substanzen

Immunoglobulin MGangliosidesAutoantibodiesganglioside, GD1bganglioside, GD1a

Autor:innen und Institutionen

  • Department of Neurology, Weill Cornell Medical Center, New York, New York, USA.

ORCID-Profile: Ruby F Ross, Jennifer A Langsdorf

Zitieren

APA

Ross, R. F., Langsdorf, J. A., & Latov, N. (2026). Newly Developing IgM Anti‐ GD1a / GD1b Ganglioside IgM Monoclonal Gammopathy in a Patient With Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Journal of the Peripheral Nervous System, 31(4). https://doi.org/10.1111/jns.70174

Vancouver

Ross RF, Langsdorf JA, Latov N. Newly Developing IgM Anti‐ GD1a / GD1b Ganglioside IgM Monoclonal Gammopathy in a Patient With Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Journal of the Peripheral Nervous System. 2026;31(4). doi:10.1111/jns.70174

BibTeX
@article{Ross2026,
  author = {Ross, Ruby F and Langsdorf, Jennifer A and Latov, Norman},
  title = {Newly Developing IgM Anti‐ GD1a / GD1b Ganglioside IgM Monoclonal Gammopathy in a Patient With Chronic Inflammatory Demyelinating Polyradiculoneuropathy},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  volume = {31},
  number = {4},
  doi = {10.1111/jns.70174}
}
Kostenlos starten →